Life-saving antibiotics are losing their power, resistance above 95 percent in ICU samples, BMU report finds
Life-saving antibiotics are losing their effectiveness one after another because of uncontrolled and irrational use. Even powerful drugs used to treat severe infections are failing against germs in many cases, making illnesses such as pneumonia, urinary tract infections and sepsis harder to treat.
The alarming picture emerges in the "Antimicrobial Resistance Report 2025-2026" published by the Department of Microbiology and Immunology of Bangladesh Medical University (BMU). According to the report, the rate of carbapenem-resistant major gram-negative bacteria rose in one year from 28.2 percent to 36.2 percent.
In respiratory samples from patients admitted to intensive care units (ICU), the resistance rate for some organisms has exceeded 95 percent.
For the report, a total of 50,844 samples from the university's outpatient and inpatient patients were analysed between July 2025 and June 2026. Bacteria were found in 13,251 of those samples.
Resistance to meropenem, a drug used for severe infections, was detected in 3,810 of 10,536 samples of the six main types of gram-negative bacteria.
The picture is more alarming by organism. Carbapenem resistance in Klebsiella rose from 27.6 percent to 40 percent. In E. coli, the rate rose from 14 percent to 20.7 percent. For Acinetobacter and Pseudomonas, known for hospital-centred infections, the resistance rates are 57.5 percent and 52.1 percent respectively.
Effectiveness is falling in common infections too. Widely used antibiotics are losing their power against E. coli, a leading cause of urinary tract infections. The report found 82.8 percent of E. coli in urine samples resistant to amoxicillin, 73.5 percent to ciprofloxacin and 92.2 percent to ceftriaxone. Resistance to nitrofurantoin also rose in one year from 33.3 percent to 50.1 percent.
In blood samples, 56 percent of Klebsiella, 62.1 percent of Acinetobacter and 33.3 percent of E. coli were resistant to meropenem. The MRSA infection rate rose from 9.7 percent in 2022-23 to 26.3 percent. Nearly 50 percent of typhoid bacteria are now resistant to ciprofloxacin, up from 40.3 percent the previous year.
According to experts, bacteria are becoming resistant because people take antibiotics without a doctor's advice, use the wrong dose, stop treatment before the scheduled time and take powerful antibiotics even when they are not needed. Weak hospital infection control and the uncontrolled use of antibiotics in poultry and livestock are also complicating the situation.
BMU Vice-Chancellor Professor Dr Md Shahinul Alam said many people around the world are dying because of the indiscriminate use of antibiotics. Once germs become resistant, antibiotics no longer work in a patient's body, so taking antibiotics without a doctor's advice must stop, and stopping pharmacy sales of antibiotics without a prescription is also urgent, he said.
The university's Pro-Vice-Chancellor (Research and Development), Professor Dr Md Mujibur Rahman Hawlader, said antibiotics have a specific dose and course that must be followed on a doctor's instructions. Because of indiscriminate use, antibiotics are not remaining effective even when patients need them to fight an infection, he said.
Experts say the impact of this crisis will not stay limited to treatment. Resistant infections can mean longer hospital stays, higher treatment costs and a greater need for intensive care. Modern treatments such as cancer chemotherapy, organ transplants and major surgery could also be put at risk. The report recommends formulating hospital-based antibiotic-use policies, strengthening infection prevention and control, increasing laboratory capacity and expanding antimicrobial stewardship programmes.
An awareness rally was held at BMU on Wednesday for World Antimicrobial Awareness Week, under this year's theme "Act now, protect our present, secure our future". The programme called on people not to use antibiotics without a doctor's advice.



